Clinical Trial: Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) in Multiple System Atrophy Type C (MSA-C) (MSA-STIM)

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06821256) titled 'Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) in Multiple System Atrophy Type C (MSA-C) (MSA-STIM)' on Feb. 06.

Brief Summary: This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).

Study Start Date: July 03, 2023

Study Type: INTERVENTIONAL

Condition: Multiple System Atrophy - Cerebellar Subtype (MSA-C)

Intervention: DEVICE: Anodal transcranial direct current stimulation (a-tDCS)

tDCS is delivered by a battery-driven constant cu...